Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (471-480 of 600) with videos related to

Pageof 60
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 1, 2014
Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trialOlga Toleva, Cynthia M Westerhout, Manohara P J Senaratne, et al.
Plos One|April 12, 2011
Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibodyTimo Heidt, Friederike Deininger, Karlheinz Peter, et al.
Basic Research in Cardiology|April 29, 2015
MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burstSteffen U Eisenhardt, Jakob B W Weiss, Christian Smolka, et al.
Circulation Research|July 24, 2010
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formationAnna Missiou, Philipp Rudolf, Peter Stachon, et al.
European Heart Journal|July 5, 2011
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudyThomas J Povsic, William A Wargin, John H Alexander, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 16, 2020
Two siblings with early repolarization syndrome: clinical and genetic characterization by whole-exome sequencingJohannes Steinfurt, Connie R Bezzina, Jürgen Biermann, et al.
The American Journal of Cardiology|December 9, 2022
Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary InterventionBatric Popovic, Gregory Ducrocq, Yedid Elbez, et al.
Scientific Reports|September 1, 2021
P<sub>2</sub>Y<sub>12</sub> receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cellsPatrick M Siegel, Laura Sander, Alba Fricke, et al.
International Journal of Cardiology|December 3, 2014
Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care SystemAnja Gutmann, Klaus Kaier, Stefan Sorg, et al.
Pageof 60

Showing results (471-480 of 600) with videos related to

Sort By:
Pageof 60
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 1, 2014
Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trialOlga Toleva, Cynthia M Westerhout, Manohara P J Senaratne, et al.
Plos One|April 12, 2011
Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibodyTimo Heidt, Friederike Deininger, Karlheinz Peter, et al.
Basic Research in Cardiology|April 29, 2015
MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burstSteffen U Eisenhardt, Jakob B W Weiss, Christian Smolka, et al.
Circulation Research|July 24, 2010
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formationAnna Missiou, Philipp Rudolf, Peter Stachon, et al.
European Heart Journal|July 5, 2011
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudyThomas J Povsic, William A Wargin, John H Alexander, et al.
American Heart Journal|December 3, 2014
How can we optimize the processes of care for acute coronary syndromes to improve outcomes?Lars Wallentin, Steen Dalby Kristensen, Jeffrey L Anderson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 16, 2020
Two siblings with early repolarization syndrome: clinical and genetic characterization by whole-exome sequencingJohannes Steinfurt, Connie R Bezzina, Jürgen Biermann, et al.
The American Journal of Cardiology|December 9, 2022
Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary InterventionBatric Popovic, Gregory Ducrocq, Yedid Elbez, et al.
Scientific Reports|September 1, 2021
P<sub>2</sub>Y<sub>12</sub> receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cellsPatrick M Siegel, Laura Sander, Alba Fricke, et al.
International Journal of Cardiology|December 3, 2014
Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care SystemAnja Gutmann, Klaus Kaier, Stefan Sorg, et al.
Pageof 60